VANCOUVER, British Columbia–(BUSINESS WIRE)–QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) announced today that it has signed definitive agreements on multiple separate transformative transactions and will be returning capital to shareholders. Together, these actions are expected to create significant liquidity and near- and long-term value for QLT shareholders. InSite Vision Acquisition: QLT has entered into a definitive agreement to acquire (the “InSite Acquisition”) InSite Visio
–(BUSINESS WIRE)–Acucela Inc. is a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, which could impact mi…
WALTHAM, Mass.–(BUSINESS WIRE)–Avedro announces that it has sold its 500th cross-linking device outside of the United States. Study data presented on its non-surgical PiXL procedure shows promise for low myopia correction.
INDIANAPOLIS–(BUSINESS WIRE)–Renaissance, a leading ancillary insurance carrier of customizable dental and vision plans, has hired industry veteran Terry Walsh as national director of sales and market development.
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it continues to fortify the scope of protection covering its retinal pigment epithelium (RPE) transplant technology with the issuance by the United States Patent and Trademark Office (USPTO) of U.S. Patent No 9,045,732. This new patent further strengthens the Company’s comprehensive suite of intellectual property which
RILLIEUX-LA-PAPE, France–(BUSINESS WIRE)–EYE TECH CARE launches its operations in China as part of its international expansion.
RILLIEUX-LA-PAPE, France–(BUSINESS WIRE)–EYE TECH CARE launches its operations in China as part of its international expansion.
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, announced that the University of Wisconsin presented a new trial concept of X-82 poster at ASCO in Chicago.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/mn2tbt/keratoconjunctivit) has announced the addition of the “Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2015” report to their offering. This repo…
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that Vicente Anido, Jr., Ph.D., Chief Executive Officer and Chairman of the Board, will present an overview of the company at the following conferences in
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that the United States Patent and Trademark Office (USPTO) issued three new U.S. Patents, Nos. 9,040,770, 9,040,039 and 9,040,038, which expand the scope of protection of the four previously issued U.S. patents covering its retinal pigment epithelium (RPE) transplant technology. These three new patents extend protection to
WATERFORD, N.Y.–(BUSINESS WIRE)–Momentive to present two technical posters highlighting the benefits of the new OphthaSil* silicone polymer product portfolio for the contact lens industry.
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ: 4573) We are pleased to announce that the phase I single-dose clinical trial for the new molecular entity RTU-1096 has been completed. RTU-1096 is a vascular adhesion protein-1 (VAP-1) inhibitor having anti-…
TOKYO–(BUSINESS WIRE)–PENTAX Medical Launches Splash M-Knife, The New Multi-Functional ESD Device
東京–(BUSINESS WIRE)–HOYA株式会社PENTAXライフケア事業部 新製品『PENTAX Medical 高周波ナイフ DN-Dシリーズ （愛称Splash M-Knife）』を販売開始
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is launching a nationwide consumer ad campaign for its Foster Grant® brand featuring its new spokesperson, popular actress and musician Kat Graham. Kat joins iconic actress and author Brooke Shields as the latest celebrity featured in the brand’s famous “Who’s that behind those Foster Grants®” campaign, which will feature ads on national network cable television as well as a digital component, slated
MUNICH–(BUSINESS WIRE)–EMA grants orphan drug designation for Isarna’s ISTH0036, a LNA-modified antisense oligonucleotide targeting TGF-β2, for the prevention of scarring post trabeculectomy in glaucoma.
WAKEFIELD, Mass.–(BUSINESS WIRE)–Optikos CEO, Stephen D. Fantone, receives Rochester Distinguished Scholar Award at the University’s 2015 Doctoral Ceremony.
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX) today announced that Chief Executive Officer Michael D. West, PhD will present at the Jefferies 2015 Global Healthcare Conference to be held in New York on June 1-4, 2015. Dr. West will pr…
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare study: comprehensive eye exams can help re-engage patients into care for certain chronic conditions, with the potential to help improve health and reduce costs.